Inaktiver Wert

Andere Sprachen Kane Biotech Inc Toronto S.E.

Aktien

KNE

CA4838092084

KNE

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Kane Biotech Q1 Loss Widens Despite Revenue Gains; to Report a Q2 Gain Following Sale of STEM Animal Health	23.05.
Kane Biotech Announces First Quarter 2024 Financial Results	23.05.
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024	16.05.
Kane Biotech Expands Wound Care Portfolio with Patented Schultz Biofilm Wound Map	15.05.
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map	15.05.
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map	15.05.
Kane Biotech to Host Investor Webinar	16.04.
Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale	15.04.
Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products	15.04.
Dechra Veterinary Products, Inc. completed the acquisition of 66.66% stake in STEM Animal Health Inc. from Kane Biotech Inc..	15.04.
Kane Biotech Agrees to Sell its Interest in STEM Animal Health for US$8 Million	11.04.
Canadian Investment Regulatory Organization Trade Resumption - KNE	11.04.
Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health	11.04.
Canadian Investment Regulatory Organization Trading Halt - KNE	11.04.
Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.03.
Kane Biotech Brief: Says otal revenue for the three months ended December 31, 2023 was $764,997	26.03.
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results	26.03.
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health	20.03.
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health	20.03.
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow	19.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Kane Biotech Inc Toronto S.E.

Aktien

KNE

CA4838092084

KNE

Andere Sprachen

Filter